Flow cytometry is an essential tool for in-process control and release testing of cell therapy products. Standardization of these analytical assays is critical for the success of the manufacturing process and final product quality. However, achieving standardization in flow cytometry can be full of hurdles. In this talk, we will review the common challenges in developing a cell therapy from pre-clinical research to the clinic. Highlights will include details on flow cytometry instrumentation, software reporting and analysis, and top quality recombinant antibody technology - all integrated into seamless, automatic workflows.
1. Explain the challenges of flow analytics in pre-clinical and clinical research.
2. Discuss quality control methods to combat sources of variation during cell analyses.
3. Explain how mitigation strategies improved data quality and time savings.